# US 2026/0124002 A1 · Systems and methods for high-bandwidth minimally invasive brain-computer interfaces

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0124002 A1
- Document ID: US20260124002A1
- Status: Published application
- Kind: A1
- Application number: 19/434,848
- Filed: 2025-12-29
- Published: 2026-05-07
- Earliest claimed: 2021-07-02
- Assignees: Precision Neuroscience Corporation
- Applicants: Precision Neuroscience Corporation
- Inventors: Benjamin Isaac RAPOPORT; Demetrios Philip PAPAGEORGIOU; Mark James HETTICK
- Web page: https://patentgrep.com/patent/US20260124002A1

## CPC

- A61B 34/20: Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
- A61B 5/0084: {for introduction into the body, e.g. by catheters (A61B5/1459 takes precedence)}
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61B 5/6868: {Brain}
- A61B 6/03: Computed tomography [CT]
- A61B 6/501: {for diagnosis of the head, e.g. neuroimaging or craniography}
- A61B 6/504: {for diagnosis of blood vessels, e.g. by angiography}
- A61B 90/10: for stereotaxic surgery, e.g. frame-based stereotaxis
- A61N 1/0531: {Brain cortex electrodes}
- A61N 1/0534: {Electrodes for deep brain stimulation}
- A61N 1/36046: {of the eye}
- A61N 1/36064: {Epilepsy}
- A61N 1/36067: {Movement disorders, e.g. tremor or Parkinson disease (stimulating motor muscle A61N1/36003)}
- A61B 5/061: {Determining position of a probe within the body employing means separate from the probe, e.g. sensing internal probe position employing impedance electrodes on the surface of the body (A61B1/00158 takes precedence)}
- A61B 5/367: Electrophysiological study [EPS], e.g. electrical activation mapping or electro-anatomical mapping
- A61B 5/37: Intracranial electroencephalography [IC-EEG], e.g. electrocorticography [ECoG]
- A61B 5/4094: {Diagnosing or monitoring seizure diseases, e.g. epilepsy}
- A61B 6/12: Arrangements for detecting or locating foreign bodies
- A61B 6/463: {characterised by displaying multiple images or images and diagnostic data on one display}
- A61B 6/487: {involving fluoroscopy}
- A61B 2090/101: {for stereotaxic radiosurgery}
- A61B 2090/376: {using X-rays, e.g. fluoroscopy}
- A61N 1/0539: {Anchoring of brain electrode systems, e.g. within burr hole}
- A61N 1/36017: {with leads or electrodes penetrating the skin}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

Systems and methods for high-bandwidth, minimally invasive brain-computer interfaces (BCIs) are disclosed. The BCIs are configured for deployment and operation in conjunction with a comprehensive interventional electrophysiology procedural suite. Three primary methods of minimally invasive electrode array delivery are disclosed: (1) cortical surface delivery, (2) ventricular delivery, and (3) endovascular delivery. Additionally, systems and methods for interacting with such high-bandwidth electrode arrays are discussed, including real-time imaging, signal processing, and neural decoding. Systems and methods for architectures for accelerating the underlying computational processes (such as graphics processing units or tensor processing units) are also discussed. Multiple applications of BCIs are discussed, with emphasis on restoration, rehabilitation, and augmentation of neurologic function.

## Claims

### Claim 1

A method for minimally invasively treating epilepsy in a patient, the method comprising:
inserting one or more electrode arrays through an entry slit formed on the patient;
advancing the one or more electrode arrays through at least a subdural space along a cortical surface to a target area on a brain of the patient;
receiving, via the one or more electrode arrays, electrical signals of the brain;
decoding the electrical signals to acquire electrical measurements of neural activity of the brain;
determining an anatomical location of the one or more electrode arrays on the brain based on the electrical measurements of neural activity;
displaying, via a display, an image comprising electrophysiological information corresponding to the anatomical location of the one or more electrode arrays; and
deploying the one or more electrode arrays to the target area on the brain of the patient, wherein the one or more electrode arrays are positioned and configured to record electrical measurements from the target area on the brain.

### Claim 2 (depends on 1)

The method of claim 1, further comprising monitoring real-time information related to a location of the one or more electrode arrays from an imaging modality during advancement of the one or more electrode arrays to the target area on the brain.

### Claim 3 (depends on 2)

The method of claim 2, wherein the imaging modality comprises at least one of fluoroscopy, computed tomography (CT), and angiography.

### Claim 4 (depends on 2)

The method of claim 2, further comprising confirming a position of the one or more electrode arrays at the target area on the brain by the image of the electrophysiological information.

### Claim 5 (depends on 1)

The method of claim 1, wherein the method is for treating impaired vision.

### Claim 6 (depends on 5)

The method of claim 5, wherein the target area on the brain comprises a visual cortex.

### Claim 7 (depends on 5)

The method of claim 5, wherein the impaired vision is related to macular degeneration in the patient.

### Claim 8 (depends on 1)

The method of claim 1, further comprising confirming a position of the one or more electrode arrays at the target area by the image of the electrophysiological information.

### Claim 9 (depends on 1)

The method of claim 1, wherein the method is for treating impairment of movement.

### Claim 10 (depends on 9)

The method of claim 9, wherein the impairment of movement is caused by a condition selected from the group consisting of: Parkinson's disease, Huntington's disease, essential tremor, ataxia, dystonia, an impulse control disorder, paralysis, stroke, spinal cord injury, and spinal cord degeneration.

### Claim 11 (depends on 1)

The method of claim 1, wherein the one or more electrode arrays comprise at least about 200 microelectrodes.

### Claim 12 (depends on 1)

The method of claim 1, wherein the one or more electrode arrays comprise at least about 500 microelectrodes.

### Claim 13 (depends on 1)

The method of claim 1, wherein the one or more electrode arrays comprise at least about 1,000 microelectrodes.

### Claim 14 (depends on 1)

The method of claim 1, wherein the method is for treating epilepsy.

### Claim 15 (depends on 14)

The method of claim 14, wherein the target area comprises a temporal lobe.
